Atlas Trials

A Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid Dependence

Clinical trial NCT00768482 · TERMINATED

Trial details

NCT number
NCT00768482
Sponsor
Titan Pharmaceuticals
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Opioid Dependence
Start date
2008-09-01
Primary completion
2008-12-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.